164 related articles for article (PubMed ID: 32827676)
1. Coamorphization combined with complexation enhances dissolution of lurasidone hydrochloride and puerarin with synchronized release.
Wang S; Heng W; Wang X; He X; Zhang Z; Wei Y; Zhang J; Gao Y; Qian S
Int J Pharm; 2020 Oct; 588():119793. PubMed ID: 32827676
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.
Heng W; Su M; Cheng H; Shen P; Liang S; Zhang L; Wei Y; Gao Y; Zhang J; Qian S
Mol Pharm; 2020 Jan; 17(1):84-97. PubMed ID: 31794225
[TBL] [Abstract][Full Text] [Related]
3. Charge-assisted bond N
Qian S; Wang S; Li Z; Wang X; Ma D; Liang S; Gao Y; Zhang J; Wei Y
Int J Pharm; 2017 Feb; 518(1-2):335-341. PubMed ID: 28043915
[TBL] [Abstract][Full Text] [Related]
4. Influence of the p
Hu Y; Guo Y; Li B; Xu R; Fang X; Cao Y; Liu Z; Jiang C; Lu S
ACS Omega; 2021 Feb; 6(4):3106-3119. PubMed ID: 33553927
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights into the crystallization of coamorphous drug systems.
Heng W; Song Y; Luo M; Hu E; Wei Y; Gao Y; Pang Z; Zhang J; Qian S
J Control Release; 2023 Feb; 354():489-502. PubMed ID: 36646287
[TBL] [Abstract][Full Text] [Related]
6. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Physical Stability and Synchronized Release of Febuxostat and Indomethacin in Coamorphous Solids.
Moinuddin SM; Shi Q; Tao J; Guo M; Zhang J; Xue Q; Ruan S; Cai T
AAPS PharmSciTech; 2020 Jan; 21(2):41. PubMed ID: 31898765
[TBL] [Abstract][Full Text] [Related]
8. Coamorphous repaglinide-saccharin with enhanced dissolution.
Gao Y; Liao J; Qi X; Zhang J
Int J Pharm; 2013 Jun; 450(1-2):290-5. PubMed ID: 23612357
[TBL] [Abstract][Full Text] [Related]
9. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
Yu D; Kan Z; Shan F; Zang J; Zhou J
Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
[TBL] [Abstract][Full Text] [Related]
10. Solid dispersion adsorbate technique for improved dissolution and flow properties of lurasidone hydrochloride: characterization using 3
Mahajan A; Surti N; Koladiya P
Drug Dev Ind Pharm; 2018 Mar; 44(3):463-471. PubMed ID: 29098883
[TBL] [Abstract][Full Text] [Related]
11. Further enhanced dissolution and oral bioavailability of docetaxel by coamorphization with a natural P-gp inhibitor myricetin.
Wei Y; Zhou S; Hao T; Zhang J; Gao Y; Qian S
Eur J Pharm Sci; 2019 Mar; 129():21-30. PubMed ID: 30590119
[TBL] [Abstract][Full Text] [Related]
12. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Potential of Mesoporous Silica as a Carrier for Puerarin: Characterization, Physical Stability, and In Vivo Pharmacokinetics.
Wang Z; Ye BN; Zhang YT; Xie JX; Li WS; Zhang HT; Liu Y; Feng NP
AAPS PharmSciTech; 2019 Aug; 20(7):289. PubMed ID: 31414349
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the Physiochemical Properties of Puerarin via L-Proline Co-Crystallization: Synthesis, Characterization, and Dissolution Studies of Two Phases of Pharmaceutical Co-Crystals.
Inam M; Liu L; Wang JW; Yu KX; Phan CU; Shen J; Zhang WH; Tang G; Hu X
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477727
[TBL] [Abstract][Full Text] [Related]
15. Sinomenine-phenolic acid coamorphous drug systems: Solubilization, sustained release, and improved physical stability.
Chen X; Li D; Zhang H; Duan Y; Huang Y
Int J Pharm; 2021 Apr; 598():120389. PubMed ID: 33609724
[TBL] [Abstract][Full Text] [Related]
16. Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: An Experimental-Theoretical Study.
Queiroz LHS; Barros RS; de Sousa FF; Lage MR; Sarraguça MC; Ribeiro PRS
Mol Pharm; 2024 Mar; 21(3):1272-1284. PubMed ID: 38361428
[TBL] [Abstract][Full Text] [Related]
17. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.
Shi X; Song S; Ding Z; Fan B; Huang W; Xu T
J Pharm Sci; 2019 Sep; 108(9):3020-3028. PubMed ID: 31067482
[TBL] [Abstract][Full Text] [Related]
18. Stable solid dispersion of lurasidone hydrochloride with augmented physicochemical properties for the treatment of schizophrenia and bipolar disorder.
Pardhi VP; Flora S
Biopharm Drug Dispos; 2020 Nov; 41(8-9):334-351. PubMed ID: 33080060
[TBL] [Abstract][Full Text] [Related]
19. Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study.
Guo W; Dong X; Li Y; Li C; Tian Y; Gao H; Li T; Zhu H; Wang J; Yang C
Eur J Pharm Biopharm; 2023 Mar; 184():139-149. PubMed ID: 36709922
[TBL] [Abstract][Full Text] [Related]
20. Design of a Stable Coamorphous System Using Lactose as an Antiplasticizing Agent for Diphenhydramine Hydrochloride with a Low Glass Transition Temperature.
Ueda H; Hirakawa Y; Miyano T; Imono M; Tse JY; Uchiyama H; Tozuka Y; Kadota K
Mol Pharm; 2022 Apr; 19(4):1209-1218. PubMed ID: 35316068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
